The rise of soluble platelet-derived growth factor receptor β in CSF early after subarachnoid hemorrhage correlates with cerebral vasospasm
- 24 Downloads
Platelet-derived growth factor β (PDGFβ) has been proposed to contribute to the development of cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH), and soluble PDGFRβ (sPDGFRβ) is considered to be an inhibitor of PDGF signaling. We aimed at determining the sPDGFRβ concentrations in the cerebrospinal fluid (CSF) of patients with aneurysmal SAH (aSAH) and analyzing the relationship between sPDGFRβ level and CVS. CSF was sampled from 32 patients who suffered aSAH and five normal controls. Enzyme-linked immunosorbent assay was performed to determine the sPDGFRβ concentrations in the CSF. Functional outcome was assessed using modified Rankin scale (mRS) at 6 months after aSAH. CVS was identified using transcranial Doppler or angio-CT or DSA. The cutoff of sPDGFRβ for CVS was defined on the ROC curve. The concentrations of sPDGFRβ following aSAH were both higher than those of normal controls on days 1–3 and 4–6, and peaked on days 7–9 post-SAH. The cutoff value of sPDGFRβ level on days 1–3 for CVS was defined as 975.38 pg/ml according to the ROC curve (AUC = 0.680, p = 0.082). In addition, CSF sPDGFRβ concentrations correlated with CVS (r = 0.416, p = 0.018), and multivariate analysis indicated that sPDGFRβ level higher than 975.38 pg/ml on days 1–3 was an independent predictor of CVS (p = 0.001, OR = 19.22, 95% CI: 3.27–113.03), but not for unfavorable outcome after aSAH in the current study. CSF sPDGFRβ level increases after aSAH and is higher in patients who developed CVS, and sPDGFRβ level higher than 975.38 pg/ml on days 1–3 is a potential predictor for CVS after SAH.
KeywordsCerebrospinal fluid Soluble platelet-derived growth factor receptor β Cerebral vasospasm Subarachnoid hemorrhage
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 3.Platz J, Güresir E, Wagner M, Seifert V, Konczalla J (2016) Increased risk of delayed cerebral ischemia in subarachnoid hemorrhage patients with additional intracerebral hematoma. J Neurosurg:1–7Google Scholar
- 5.Mats Hellström MKPL (1999) Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047–3055Google Scholar
- 6.Dong A, Seidel C, Snell D, Ekawardhani S, Ahlskog JKJ, Baumann M, Shen J, Iwase T, Tian J, Stevens R, F. Hackett S, Stumpp MT, Campochiaro PA (2014) Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A. Angiogenesis 17(3):553–562Google Scholar
- 11.Ishii Y, Oya T, Zheng L, Gao Z, Kawaguchi M, Sabit H, Matsushima T, Tokunaga A, Ishizawa S, Hori E, Nabeshima YI, Sasaoka T, Fujimori T, Mori H, Sasahara M (2006) Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury. J Neurochem 98:588–600CrossRefPubMedGoogle Scholar
- 12.Chen Y, Li Q, Tang J, Feng H, Zhang JH (2015) The evolving roles of pericyte in early brain injury after subarachnoid hemorrhage. Brain Res 1623:110–122Google Scholar
- 14.Bar B, MacKenzie L, Hurst RW, et al (2016) Hyperacute vasospasm after aneurysmal subarachnoid hemorrhage. Neurocrit Care 24(2):180–188Google Scholar
- 16.Bondjers C, Hellstro M, Abramsson A, Lindahl P, Betsholtz C (2003) Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol 162(3):721–729Google Scholar
- 19.Li H, Yu J, Zhang D et al (2017) Inhibition of the receptor for advanced glycation end-products (RAGE) attenuates neuroinflammation while sensitizing cortical neurons towards death in experimental subarachnoid hemorrhage. Mol Neurobiol 54(1):755–767Google Scholar